Skip to main content
logo
MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
11.41
-0.06 (-0.52%)
At close: Oct 2, 2026, 4:00 PM EDT
11.27
-0.14 (-1.19%)
After-hours: Oct 2, 2026, 7:51 PM EDT

MLTX Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
9719413,4153,620409-
Market Cap Growth
116.60%-72.45%-5.66%784.47%--
Enterprise Value
5366382,9323,189353-
Last Close Price
11.4113.1854.1560.3910.509.89

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.233.097.537.055.95-
P/TBV Ratio
2.273.097.647.308.37-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.240.250.010.010.00-1.29
Net Debt / Equity Ratio
-1.02-1.04-0.98-0.99-1.04-0.60
Net Debt / EBITDA Ratio
1.641.313.149.441.11-0.20
Net Debt / FCF Ratio
1.931.623.8011.781.29-0.16
Quick Ratio
11.988.7720.0751.389.440.39
Current Ratio
12.569.2721.1151.599.980.46
Return on Equity (ROE)
-67.47%-60.78%-25.08%-15.14%-225.86%-
Return on Assets (ROA)
-32.44%-33.92%-17.81%-11.21%-93.99%-
Return on Capital Employed (ROCE)
-50.80%-64.60%-31.40%-10.50%-94.00%300.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-27.15%-24.16%-3.48%-1.00%-12.21%-
FCF Yield
-23.19%-20.84%-3.43%-1.19%-13.66%-
Buyback Yield / Dilution
-9.53%-2.54%-27.99%-67.30%-274.47%-
SEC Filings: 10-K · 10-Q